# Aripiprazole

## Abilify Maintena inj 400mg

| 藥物代碼           | IABI                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Bipolar I disorder, Schizophrenia,                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 副作用             | Headache, asthenia, accidental injury, peripheral edema, hypertension, GI disturbances, myalgia, agitation, anxiety, insomnia, lightheadedness, somnolence, akathisia, extrapyramidal syndrome, tremor, increased salivation, rhinitis, pharyngitis, coughing, blurred vision.Endocrine metabolic: Weight increased (2% to 30% )Gastrointestinal: Constipation (5% to 11% ), Nausea (8% to 15% ), Vomiting (3% to 11% )Neurologic: Akathisia (2% to 25% ), Dizziness (4% to 10% ), Extrapyramidal disease (2% to 27.3% ), Headache (12% to 27% ), Insomnia (8% to 18% ), Sedated (1% to 8% ), Somnolence (5% to 26.3% ), Tremor (2% to 11.8% )Ophthalmic: Blurred vision (3% to 8% )Psychiatric: Anxiety (4% to 17% ), Restlessness (2% to 12% )Other: Fatigue (2% to 11% ) |
| 禁忌               | Hypersensitivity to aripiprazole or any component of the formulation.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |
| 藥物保存方式       | 30度C以下                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
| 用法用量           | 400 mg once monthly (doses should be separated by more than 26 days); Tolerability should be established using oral aripiprazole prior to initiation of parenteral therapy; due to the half-life of oral aripiprazole it may take up to 2 weeks to fully assess tolerability. Continue oral aripiprazole (or other oral antipsychotic) for 14 days during initiation of parenteral therapy.                                                                                                                                                                                                                                                                                                                                                                                 |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 懷孕用藥危分級     | 除非治療上需要                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 孕期用藥建議       | No (Limited) Human Data - animal data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 哺乳期用藥建議     | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 注射劑給藥建議途徑 | IM                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| 乾粉稀釋液         | 使用預充填雙腔注射筒內含之注射用水，依仿單指示進行混合。                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 注意事項           | 1.溶液應於配置後30分鐘使用完畢. 2.請依仿單建議針對不同的病患選用不同的針頭. 3.不要搓揉注射部位.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |

## Abilify 5mg

| 藥物代碼           | OABI                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
|:-------------------|:----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| 適應症             | Schizophrenia in adults & adolescents 13-17 years. Monotherapy or adjunctive therapy to either lithium or valproate for the acute manic & mixed episodes associated with Bipolar I disorder in adults & pediatrics 10-17 years. Adjunctive treatment of major depressive disorders. Irritability associated with autistic disorder in pediatric patients 6-17 years.                                                                                                                                                                                                                                                                                                                                                                                                        |
| 副作用             | Headache, asthenia, accidental injury, peripheral edema, hypertension, GI disturbances, myalgia, agitation, anxiety, insomnia, lightheadedness, somnolence, akathisia, extrapyramidal syndrome, tremor, increased salivation, rhinitis, pharyngitis, coughing, blurred vision.Endocrine metabolic: Weight increased (2% to 30% )Gastrointestinal: Constipation (5% to 11% ), Nausea (8% to 15% ), Vomiting (3% to 11% )Neurologic: Akathisia (2% to 25% ), Dizziness (4% to 10% ), Extrapyramidal disease (2% to 27.3% ), Headache (12% to 27% ), Insomnia (8% to 18% ), Sedated (1% to 8% ), Somnolence (5% to 26.3% ), Tremor (2% to 11.8% )Ophthalmic: Blurred vision (3% to 8% )Psychiatric: Anxiety (4% to 17% ), Restlessness (2% to 12% )Other: Fatigue (2% to 11% ) |
| 禁忌               | Known hypersensitivity to aripiprazole.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                     |
| 藥物保存方式       | 室溫                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 用法用量           | Maintenance for acute schizophrenia & bipolar disorder: 10 or 15 mg once daily. Max of 30 mg/day. Adjunctive therapy for major depressive disorder: Initial dose: 2-5 mg/day. Max of 15 mg/day.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |
| 肝功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 腎功能異常         | 無需調整劑量                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |
| 懷孕用藥危分級     | 除非治療上需要                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |
| 孕期用藥建議       | Human data suggest low risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 哺乳期用藥建議     | No (Limited) Human Data - Potential Toxicity 無(很少)資料 - 避免使用                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |
| 附帶說明           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 注射劑給藥建議途徑 | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 乾粉稀釋液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 輸注點滴液         | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| IVP 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| IVD 用法建議       | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |
| 注意事項           | N/A                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                         |

